Updated Palestinian EDL (Core List) and CDL Vial: 0.25% Injection for spinal anesthesia: 0.5% in 4‐ml amp to be mixed with 7.5% glucose solution Lidocaine HCl + Epinephrine (adrenaline) 1.3 Preoperative medication and sedation for short-term procedures 2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORY MEDICINES (NSAIMs), MEDICINES USED TO TREAT GOUT AND DISEASE MODIFYING AGENTS IN RHEUMATOID DISORDERS (DMARDs) 2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) Injection: 10 mg in 1ml ampoule Tablet (prolonged release): 10 mg; 2.4 Disease modifying agents used in rheumatoid disorders (DMARDs) 3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS E03002104 4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS Injection: 20%. 10 mL Injection: 1 mg (sulfate) in 1‐ml Tablet: 250 mg Powder for injection: 500 mg Injection: 1%. Injection: 0.4 mg/ mL in 1‐ml 5. ANTICONVULSANTS/ANTIEPILEPTICS E05003104 Tablet: 500 mg + 125 mg Oral Liquid (Suspension):400 mg Powder for injection: 1 g in vial. Powder for injection: 900 mg benzylpenicillin (= 1.2 million IU) in 5 -ml. Injection: 10 million IU Suspension (Powder for reconstitution with water): 250 mg/5 mL. 100 mL Injection: 1 gm in a vial Powder for oral liquid: 250 mg (as Nucleoside/Nucleotide reverse transcriptase inhibitors 6.5.1 Antiamoebic and antigiardiasis medicines Hydroxychloroquine as phosphate or sulfate 6.5.4 Antipneumocystosis and antitoxoplasmosis medicines 8. ANTINEOPLASTIC, IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE 8.1 Immunosuppressive and Immunostimulants Injection: 1 gram in vial Powder for injection: 10 000 IU in Injection: 2000 I.U Solution: 50 mg/ ml elemental iron Injection: 100 mg /5mg IU Injection: 1000 mcg in 1‐ml 10.3 Other medicines for haemoglobinopathies 11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES Tablet: 5 mg Oral liquid (Elixir): 0.05 mg/ml. 60 Tablet: 250 mg. Powder for infusion: 50 mg in Tablet: 75 mg. Powder for injection: 1.5 million IU 13.3 Anti-inflammatory and antipruritic medicines 13.4 Medicines affecting skin differentiation and proliferation Calcipotriol 50 mcg/g + Betamethasone 0.5 mg/ Salicylic acid + Benzocaine in a colloidal base. Powder, 5 Kg. Injection: 0.679 gm\ ml- 100 ml in Meglumine ioxitalmate + Sodium ioxitalamate 17.1. Antacids & Antiulcer medicines Aluminium hydroxide gel + Mg trisilicate Adult supp: 2.7 grams Syrup: 50% + 8% + 5% w/w. 100 Pancreatin ( protease +lipase + amylase) 18. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES 18.1 Adrenal hormones and synthetic substitutes 18.5 Insulin and other medicines used for diabetes Tuberculin, purified protein derivative (PPD) Infusion : 5%, 100 mL Injection: 250 micrograms in Poliomyelitis vaccine (Polio Salk vaccine) Poliomyelitis vaccine (Polio Oral vaccine) 20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS E20001208 Tablet: 60 mg. Injection: 50 mg /ml in 2‐ml 21.4 Miotics and anti-glaucoma medicines Solution (eye drops): 2%, 4% Solution (eye drops): 0.5% (as 24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS 24.1 Medicines used in psychotic disorders 24.2.1 Medicines used in depressive disorders 24.2.2 Medicines used in bipolar disorders 24.4 Medicines used for obsessive compulsive disorders 25. MEDICINES ACTING ON THE RESPIRATORY TRACT Aerosol: 400 micrograms Inhalation (aerosol): 20 micrograms/metered dose Solution for nebulization 0.25 mg/mL. 25 mL. Inhalation (aerosol): 100 micrograms per dose Respiratory solution for use in 26.Solutions correcting water, electrolyte and acid -base Solution : 500 ml Injectable solution: 5% (isotonic). 1 Injectable solution: 10% (hypertonic) Injectable solution: 50% Injectable solution: 20% Injectable solution: 5% + 0.9%. 500 27. VITAMINS, MINERALS AND OTHER NUTRITIONAL SUPPLEMENTS Nutramigen 425 or alike (hydrolysed cow milk Phenylalanine- free formula for children Prosobee or alike (soya protein based formula). 29. SPECIFIC MEDICINES FOR NEONATAL CARE E29001204 Solution for Injection: 0.5 mg/ ml. Injection: 20 mg/ml (equivalent to 10 mg caffeine base/ml). Oral liquid: 20 mg/ml (equivalent to

Source: http://www.wafainfo.ps/pdf/Medicines_List_2013.PDF


Parents and Educators Need to be Aware of the Health Risks of Consuming Energy Drinks Prince Edward Island Home and School Federation March 20, 2009 The Prince Edward Island Home and School Federation thanks the provincial“Standing Committee on Social Development,” for the opportunity to forward ourconcerns and ideas on the sale of “energy drinks”. The Federation’s


Therapeutic and Pharmacologic Differences between Medications Used in the Treatment of Bipolar Disorders: Seven-Year UpdateA detailed review was published in 2004 on the sus propiedades terapéuticas en las diferentes fases de los therapeutic properties of the medications used in the trastornos bipolares llevando a proponer un cambio en treatment of bipolar disorders (Tamayo, JM et al. Actas

Copyright © 2010-2014 Metabolize Drugs Pdf